학술논문
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study
Document Type
Article
Author
Source
In eBioMedicine August 2023 94
Subject
Language
ISSN
2352-3964